SARAH HUGHES: Open Payments
NPI 1083324594 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 60 payments from 14 companies in 2025. Trend: 2023 $100 · 2024 $519 · 2025 $1,509
Food & beverage: $1,309Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $247 |
| Novartis Pharmaceuticals Corporation | 5 | $221 |
| ABBVIE INC. | 12 | $175 |
| UCB, Inc. | 13 | $172 |
| Galderma Laboratories, L.P. | 5 | $168 |
| LEO Pharma Inc. | 2 | $167 |
| Amgen Inc. | 5 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $57 |
| Incyte Corporation | 2 | $56 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $45 |
Products named: TREMFYA, Bimzelx, Rhapsido, NEMLUVIO, RINVOQ, OTEZLA, COSENTYX, ILUMYA.
Industry payments across MO — which companies pay providers there.
